Anadys’ ANA773 Hepatitis C Phase I Trials in Netherlands

July 22nd, 2008 by

admin

Reducing the dosing schedule in half, Anadys Pharmaceuticals continues its enquiry of ANA773, a Toll-Like Receptor-7 character prodrug. Approaching the Hepatitis C virus differently from most another contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load fall of…

Posted in Hepatology |

Related posts

Comments are closed.

Recent Posts

Can Coffee Lower Your Cholesterol?
New Publication Shows Cleviprex™ Provides More Precise Blood Pressure Control In Cardiac Surgery Patients
ResMed Announces First Major Study To Investigate How Breathing Difficulties During Sleep Affect Heart Failure Patients
Efforts, Events Seek To Improve Health Of Pacific Islanders, Reduce Cardiovascular Disease Among Blacks, Offer Support For Hispanic Nurses, Other
Newly Identified Cells Make Fat
Physio-Control Receives FDA 510(k) Clearance For LIFEPAK(R) 20e Defibrillator/Monitor
Western Reserve Heart Care Opens Vascular Laboratory To Diagnose And Treat Arterial Disease In Hudson
Cook Medical’s Drug-eluting Peripheral Vascular Stent, The Zilver PTX, Will Be Manufactured At Its Limerick, Ireland Plant
Health Services Research Finds Specialty Hospitals Not More Cost-Efficient Than Full-Service Hospitals
2008 Therapeutic Temperature Management Congress Opens To Hundreds In Barcelona

Categories

Archives:

Search: